A combination of 5-azacytidine and nivolumab is a potentially effective rescue therapy in relapsed/refractory AITL

Overview of attention for article published in Frontiers in immunology, June 2024

Altmetric Badge

Mentioned by

twitter: 1 X user

So far, Altmetric has seen 1 X post from an account with 1,222 followers.

https://t.co/2L0VJDVPih

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.